Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-03-02 @ 6:08 PM
Study NCT ID:
NCT02345460
Status:
TERMINATED
Last Update Posted:
2018-07-13
First Post:
2015-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study
Sponsor:
Case Comprehensive Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pancreatic Adenocarcinoma | View |
| None | Poorly Differentiated Malignant Neoplasm | View |
| None | Resectable Pancreatic Cancer | View |
| None | Stage IA Pancreatic Cancer | View |
| None | Stage IB Pancreatic Cancer | View |
| None | Stage IIA Pancreatic Cancer | View |
| None | Stage IIB Pancreatic Cancer | View |
| None | Stage III Pancreatic Cancer | View |
| None | Undifferentiated Pancreatic Carcinoma | View |
Keywords: